PMID- 38482843 OWN - NLM STAT- MEDLINE DCOM- 20240403 LR - 20240404 IS - 1552-3365 (Electronic) IS - 0363-5465 (Print) IS - 0363-5465 (Linking) VI - 52 IP - 5 DP - 2024 Apr TI - Risk Factors for Rerupture After Proximal Hamstring Avulsion Injury Including the Optimal Timing for Surgery. PG - 1173-1182 LID - 10.1177/03635465241233734 [doi] AB - BACKGROUND: Despite the prevalence of proximal hamstring avulsion injuries (PHAIs), the understanding of rerupture risk factors and the influence of injury chronicity on these rates remain limited. PURPOSE: To investigate the rerupture rate after PHAI repair and identify its associated risk factors and the optimal time to primary surgery. STUDY DESIGN: Case-control study; Level of evidence, 3. METHOD: This is a retrospective analysis of prospectively collected data from the French Proximal Hamstring Avulsion Surgery Cohort Study targeting patients surgically treated for PHAI between 2002 and 2022. The primary outcome measure of this study was the rerupture rate of PHAI repair. The secondary outcome measures included the assessment of the potential risk factors for rerupture as well as the investigation of the incidence rate of rerupture for 100 person-years depending on various injury-surgery delay definitions. RESULTS: This study analyzed 740 patients with a mean age of 45.9 years (SD, 13.6 years) and followed up for a mean of 4.9 years (SD, 3.9 years). The rerupture rate was 4.59% (34/740). Most reruptures (75%) occurred within the first 6 months after surgery (median, 88.5 days; interquartile range, 39.5-182 days), and 74% were atraumatic. Univariate analysis identified potential risk factors: longer initial surgery delay (hazard ratio [HR], 1.03; 95% CI, 1.01-1.04; P = .04) and initial complete ruptures (HR, 4.47; 95% CI, 1.07-18.7; P = .04). Receiver operating characteristic curve analysis found the optimal injury-surgery delay cutoff predicting rerupture to be 32 days (area under the curve, 0.62; 95% CI, 0.53-0.71). The relative Youden index was calculated at 0.24, corresponding to a sensitivity of 65% and a specificity of 59%. Surpassing this cutoff showed the highest HR (2.56), narrowest 95% CI (1.27-5.17), and highest incidence of rerupture (1.42 per 100 person-years) (P = .01). In the multivariate analysis, an injury-surgery delay of >32 days (HR, 2.5; 95% CI, 1.24-5.06; P = .01) and initial complete ruptures (HR, 4.33; 95% CI, 1.04-18.08; P = .04) emerged as significant risk factors for rerupture. CONCLUSION: This study found a 4.59% rerupture risk after PHAI repair. Most reruptures (75%) occurred within the first 6 months after surgery. Risk factors for rerupture included chronicity and initial complete injury. The optimal threshold for chronicity of PHAI lesions, based on rerupture rate, was marked by an injury-surgery delay of >32 days. FAU - Lefevre, Nicolas AU - Lefevre N AD - Clinique du sport, Paris, France. FAU - Freiha, Kinan AU - Freiha K AUID- ORCID: 0009-0002-4594-3187 AD - Clinique du sport, Paris, France. FAU - Moussa, Mohamad K AU - Moussa MK AD - Clinique du sport, Paris, France. FAU - Valentin, Eugenie AU - Valentin E AD - Clinique du sport, Paris, France. FAU - Bohu, Yoann AU - Bohu Y AD - Clinique du sport, Paris, France. FAU - Meyer, Alain AU - Meyer A AD - Clinique du sport, Paris, France. FAU - Hardy, Alexandre AU - Hardy A AD - Clinique du sport, Paris, France. LA - eng PT - Journal Article DEP - 20240314 PL - United States TA - Am J Sports Med JT - The American journal of sports medicine JID - 7609541 SB - IM MH - Humans MH - Middle Aged MH - Cohort Studies MH - Retrospective Studies MH - Case-Control Studies MH - *Hamstring Muscles/surgery/injuries MH - *Leg Injuries MH - Risk Factors MH - *Soft Tissue Injuries MH - Rupture/surgery PMC - PMC10986149 OTO - NOTNLM OT - chronicity OT - proximal hamstring avulsion injuries OT - rerupture OT - risk factors OT - surgical repair COIS- One or more of the authors has declared the following potential conflict of interest or source of funding: N.L. is a consultant for WebSurvey Society, Paris, France. A.H. is a consultant for Arthrex and DePuy. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. EDAT- 2024/03/14 12:49 MHDA- 2024/04/03 06:44 PMCR- 2024/04/02 CRDT- 2024/03/14 08:02 PHST- 2024/04/03 06:44 [medline] PHST- 2024/03/14 12:49 [pubmed] PHST- 2024/03/14 08:02 [entrez] PHST- 2024/04/02 00:00 [pmc-release] AID - 10.1177_03635465241233734 [pii] AID - 10.1177/03635465241233734 [doi] PST - ppublish SO - Am J Sports Med. 2024 Apr;52(5):1173-1182. doi: 10.1177/03635465241233734. Epub 2024 Mar 14.